Dr. Alex Weisman, Ph.D. in biochemistry, is the founder and owner of Calathea Pharma Ltd., a consulting company providing scientific and business development services in Chemistry, Manufacturing, and Controls for companies and government institutions. Dr. Weisman has held executive positions as VP R&D and Chief Scientist at a number of Israeli and international pharmaceutical companies and currently serves as an advisor and management team member of companies developing new products for the chemicals, pharmaceuticals, and food industries. With more than 30 years of experience in the development, characterization, scale-up, technology transfer, troubleshooting, production, and registration of novel and generic drugs, as well as other pharmaceutical and chemical products, Dr. Weisman brings extensive expertise to his consulting role.